Physiological and molecular effects of Apo2L/TRAIL and cisplatin in ovarian carcinoma cell lines

This publication has 28 references indexed in Scilit:

• Suppression of Tumor Growth Following Intralesional Therapy with TRAIL Recombinant Adenovirus
  Molecular Therapy, 2001
• TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications
  Blood, 2001
• DEATH RECEPTORS AND APOPTOSIS
  Cardiology Clinics, 2001
• TRAIL/Apo-2L: Mechanisms and Clinical Applications in Cancer
  Neoplasia, 2001
• Intracellular Mechanisms of TRAIL and Its Role in Cancer Therapy
  Molecular Cell Biology Research Communications, 2000
• Ovarian cancer: Epidemiology, biology, and prognostic factors
  Seminars in Surgical Oncology, 2000
• Epithelial ovarian cancer: prevention, diagnosis, and treatment
  CA: A Cancer Journal for Clinicians, 1999
• Apoptosis control by death and decoy receptors
  Published by Elsevier ,1999
• Epithelial ovarian cancer
  Current Problems in Surgery, 1999
• Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors
  Science, 1997